EndoSerter Approved By FDA for Corneal Transplants

March 7, 2011

The FDA has approved the Endoserter, a new instrument from Ocular Systems, Inc., that makes the process of inserting the donor endothelium during DSAEK (Partial Thickness Corneal Transplant Endothelial Keratoplasty) easier and less traumatic. No pulling or folding.

DSAEK is a great advance  in cornea transplant surgery, and the progress made in the past few years has been remarkable.

Click here to read Ocular Systems press release.

 

 



Comments

Jump down to form below to submit your own comments

2 Responses to “EndoSerter Approved By FDA for Corneal Transplants”

  • Dr. Ari Weitzner

    there is absolutely no reason you cant do cataract surgery alone w/o the dsaek. if the cornea fails, then you will simply have to make a second trip to the o.r. in a few months and have it done- not the end of the world.

  • Barry Paul T.

    I am a 66 year old male with only one eye that eye had a corneal transplant 48 years ago. The graft still has 1000 cells, but I developed a moderate cataract 12 years ago. My Corneal Surgeon refuses to remove the cataract only, as he wants to do the DSAEK at the same time. I am scared. I live in Harrisburg, Pa. & need advise on what to do. My present vision is 20/40.

    Trackback URL
    http://eyedocnews.com/004973-new-instrument-for-dsaek-approved-by-fda/trackback/

    Have insights to contribute? Please submit your comment below